Sat.Nov 12, 2022 - Fri.Nov 18, 2022

Extra Hot Nanoparticles for Cancer Therapy

Medgadget

Researchers at Oregon State University created a new type of hyperthermic magnetic nanoparticle that is intended to assist in destroying tumors through localized heating under an alternating magnetic field.

To explore cancer’s genetic mysteries, researchers turn to ‘MACHETE’

PharmaVoice

A new CRISPR-based tool could help scientists understand and better treat cancer by revealing the complex genetic mutations that occur

87

Ultimate Door to Door Sales Guide (With Tips & Scripts)

Spotio

Looking to level-up your door to door sales process in 2022? This guide is for you. Let’s be honest. There is a stigma around door to door sales and that it’s an antiquated way of selling.

Sun Pharma- Walk In Interviews for B.Sc / B.Pharm/  Diploma/ ITI/ B.E in Production/ Engineering Dept. On 20th Nov’ 2022

Pharma Pathway

Sun Pharma- Walk In Interviews for B.Sc / B.Pharm/ Diploma/ ITI/ B.E in Production/ Engineering Dept. On 20th Nov’ 2022. Job Description. Walk-In Interviews for Female Candidates. Department: Production/ Engineering. Division: Technician/ Officer/ Senior Officer.

Implantable Device Adheres to Muscle, Treats Atrophy

Medgadget

Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard have developed a mechanically active gel-elastomer-nitinol tissue adhesive, otherwise known as MAGENTA. The implantable device functions as a soft robot, and it can be adhered to the outside of a muscle.

4 pioneering social media campaigns in pharma this year

PharmaVoice

The key to a great social media campaign is often simplicity, and these pharma companies hit the nail on the head with unique strategies that aim to educate

Media 85

More Trending

Jubilant Biosys Limited- Walk-In Drive for Freshers & Experienced On 20th Nov’ 2022

Pharma Pathway

Jubilant Biosys Limited- Walk-In Drive for Freshers & Experienced On 20th Nov’ 2022. Job Description. Walk-In Drive for Freshers & Experienced On 20th Nov’ 2022 @ Jubilant Biosys Limited. Walk-In Drive @ Jubilant Biosys Limited.

Making Tumors Tastier for the Immune System

Medgadget

Researchers at The University of Texas MD Anderson Cancer Center have developed a nanotechnology platform that can make cancer cells more vulnerable to immune attack in the body. The researchers call their system the bispecific tumor-transforming nanoconjugate (BiTN) platform.

Instead of Drug Spending Caps, Medicare Should Try Value-Based Contracting

PharmExec

New regulations may require regulators to explore new payment options.

82

A ‘bold vision’ to prevent diabetes

PharmaVoice

Despite hearing that there’s “no money in prevention,” the CEO of Sigrid Therapeutics is forging ahead with the company’s goal of stopping Type 2 diabetes before it starts

83

Sun Pharma- Walk In Interviews for B.Sc / M.Sc/ B.Pharm/ M.Pharm/ B.E/ Diploma Female Professionals On 19th Nov’ 2022

Pharma Pathway

Sun Pharma- Walk In Interviews for B.Sc / M.Sc/ B.Pharm/ M.Pharm/ B.E/ Diploma Female Professionals On 19th Nov’ 2022. Job Description. Sun Pharmaceuticals Industries Ltd, Baska -Near Vadodara, Gujarat. Walk In Interviews for B.Sc / M.Sc/ B.Pharm/ M.Pharm/ B.E/

Virtual Tools for Promoting Diversity in Pharma and Clinical Trials

Impetus Digital

A version of this article was previously published in the Journal of mHealth. It is no secret that Pharma (still) has a major diversity problem. Not only on their own senior leadership teams but also in their clinical trials.

Non-Invasive Spinal Modulation for Cerebral Palsy

Medgadget

SpineX , a medtech company based in California, has developed the Spinal Cord Innovation in Pediatrics (SCiP) device, a non-invasive spinal cord neuromodulation technology that is intended to treat children with cerebral palsy.

Is AI just hype or a real revolution in pharma? It’s complicated

PharmaVoice

Artificial intelligence can be a useful tool and will likely augment many processes in biopharma — but it's still early days, and hype is rampant

Eugia Pharma -Walk-In Interviews for Production On 19th Nov’ 2022

Pharma Pathway

Eugia Pharma -Walk-In Interviews for Production On 19th Nov’ 2022. Job Description. Eugia Pharma Specialities Limited is Subsidiary of Aurobindo Pharma Limited, Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8

Early cell therapy successes start to turn the tide in lupus

Pharmaceutical Technology

In a field dominated by antibodies and small molecules, two cell-therapy based approaches have come under the spotlight for showing early signs of efficacy in treating lupus.

Ferrobot Swarms for Rapid Viral Testing

Medgadget

At the University of California Los Angeles, scientists have developed a handheld lab kit that can conduct automated pooled testing for viral diseases, including COVID-19.

#HLTH: ‘Unicorns are real’ — and here’s how they can navigate a challenging biotech market

PharmaVoice

Venture capitalists tackle ways companies can stay afloat while the market’s turbulent waters rise

Sun Pharma- Walk In Interviews for B.Sc / M.Sc/  Diploma-Engineering/ ITI in Production On 19th Nov’ 2022

Pharma Pathway

Sun Pharma- Walk In Interviews for B.Sc / M.Sc/ Diploma-Engineering/ ITI in Production On 19th Nov’ 2022. Job Description. Walk In Interviews for B.Sc / M.Sc/ Diploma-Engineering/ ITI in Production On 19th Nov’ 2022 @ Sun Pharma. Department: Production. Division: API.

In Arkansas and Michigan, Voters “Defund” Public Libraries

Copyright Clearance Center

The post In Arkansas and Michigan, Voters “Defund” Public Libraries appeared first on Copyright Clearance Center. CCC in the News

77

Two Pharmacy Owners Plead Guilty in $18M Foreign Medicare Fraud Scheme

MedCity News

The scheme started in New York but became a complex international endeavor as the two men attempted to launder money received from fraudulent Medicare claims for cancer drugs during the pandemic.

Why the IRA will drive up the country’s drug bill — not lower it

PharmaVoice

On the surface, the Inflation Reduction Act is designed to lower drug prices, but its impact on innovation incentives could produce a landscape of new medicines that are costlier for patients

Hetero Limited-Campus Interview for Freshers -Production/ QA/ QC/ R&D/ Maintenance  On 21st Nov’ 2022

Pharma Pathway

Hetero Limited-Campus Interview for Freshers -Production/ QA/ QC/ R&D/ Maintenance On 21st Nov’ 2022. Job Description. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Cader Unravels Judge Pan’s Ruling To Block PRH/S&S Merger

Copyright Clearance Center

The post Cader Unravels Judge Pan’s Ruling To Block PRH/S&S Merger appeared first on Copyright Clearance Center. CCC in the News

76

How Behavioral Healthcare Practices Can Reduce No-show Appointments

MedCity News

By taking a few simple steps, practices can help ensure that their patients get the care they need while reducing unnecessary losses of revenue and time within the business model. Daily Health Tech MedCity Influencers Physicians SYN Top Story behavioral health Mental Health

FDA Clearance Awarded to Tyber Medical for NiTy+ One-Shot Staple Fixation System

Legacy MEDSearch

Tyber Medical LLC, the global, leading private-label medical device provider for major orthopedic trauma, extremity, and spine companies, has been awarded a U.S. Food and Drug Administration (FDA) 510(k) clearance for its new NiTy+ One-Shot Staple Fixation System.

Vital Pharma -Walk-In Drive for Freshers & Experienced in Dispatch Sales Dept. On 18th & 19th Nov’ 2022

Pharma Pathway

Vital Pharma -Walk-In Drive for Freshers & Experienced in Dispatch Sales Dept. On 18th & 19th Nov’ 2022. Job Description. Walk-In Drive for Freshers & Experienced in Dispatch Sales Dept. On 18th & 19th Nov’ 2022@ Vital Therapeutics & Formulation Pvt.

Advanced therapies and the high-profile pricing dilemma

Pharma Phorum

The advancements made in drug development over the last decade have seen the arrival of a number of treatments that offer one-time cures and more effective therapies for conditions in smaller patient populations.

Pharma 104

Provention Wins FDA Approval for First Drug to Delay Type 1 Diabetes Progression

MedCity News

Type 1 diabetes patients now have a new therapeutic option for the autoimmune disorder. Provention Bio drug Tzeild has received FDA approval for delaying the onset of the most severe stage of this chronic disease.

FDA 101

MHRA approves first gene therapy for infusion into the brain

European Pharmaceutical Review

Upstaza (eladocagene exuparvovec) is the first and only approved treatment for aromatic L-amino acid decarboxylase (AADC) deficiency and is the first marketed gene therapy for direct infusion into the brain.

Dr. Reddy’s Laboratories Ltd.-Walk-In Interviews for MSAT & ASAT – API, OSD & Injectable On 20th Nov’ 2022

Pharma Pathway

Reddy’s Laboratories Ltd.-Walk-In Walk-In Interviews for MSAT & ASAT – API, OSD & Injectable On 20th Nov’ 202. Job Description. Dr. Reddy’s Laboratories Ltd.

Data privacy concerns don’t hinder digital health app usage

Pharma Phorum

A new survey conducted by juli, an AI-powered chronic condition platform, has revealed that the value placed on digital privacy differs widely among US users.

With Its New, Outsourced Virtual Care Model, Will the Third Time Be the Charm for Amazon?

MedCity News

Instead of building its own network of providers and bringing hybrid care services to employers like it did with Amazon Care, the new Amazon Clinic model is direct-to-consumer and outsources to third-party providers.

Retail 101

Hybrid work is here to stay — here’s how leaders should adjust

PharmaVoice

Executives across the life sciences share their tips for navigating the new norm of remote work

69